Covaxin volunteer showed adverse effect during Phase 1 trials, Says Report; Bharat Biotech claims illness 'unrelated' to vaccine
Image Credit: shortpedia
During the Phase 1 trials of Bharat Biotech's COVID-19 vaccine- Covaxin, a 35-year-old healthy male volunteer who was given a shot of the vaccine on July 15 had developed viral pneumonitis and was hospitalised for a week in Nagpur, according to a report. Bharat Biotech claims that viral pneumonitis was not caused because of vaccine and it was reported to the regulatory authorities within 24 hours of confirmation about it.